Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A

Thrombosis Research

Volumn 97, Issue 4, 2000, Pages 227-230

  Akar, N ^a   Yilmaz, E ^a   Akar, E ^a   Avcu, F ^b   Yalcin A ^b   Cin, Ş ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Factor V; Plasminogen activator inhibitor 1; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FIBRINOLYSIS; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PLASMINOGEN ACTIVATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; VEIN THROMBOSIS;

ADULT; CASE-CONTROL STUDIES; FACTOR V; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; RISK FACTORS; TURKEY; VENOUS THROMBOSIS;

EID: 0033967394     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00164-4     Document Type: Article

References (12)

1. Rosendaal F.R. Risk factors for venous thrombosis. Prevalance, risk and interraction Semin Hematol. 34:1997;171-187.
2. Wiman B., Hamsten A. Impaired fibrinolysis and risk of thromboembolism. Prog Cardiovasc Dis. 34:1991;179-192.
3. Burzotta F., Di Castelnuovo A., Amore C., D'Orazio A., Di Bitondo R., Donati M.B., Iacoviello L. 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1activity in Italians. A model of gene-environment interaction Thromb Haemost. 79:1998;354-358.
4. Zöller B., de Frutos P.C., Dahlbäck B. A common 4G allele in the promoter of the plasminogen activator inhibitor -1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Thromb Haemost. 79:1998;802-807.
5. Stegnar M., Uhrin P., Peternel P., Mavri A., Salobir-Pajnic B., Stare J., Binder B.R. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene. Relationship to plasma PAI-1 level in venous thromboembolism Thromb Haemost. 79:1998;975-979.
6. Junker R., Nabavi D.G., Wolff E., Lüdemann P., Nowak-Göttl U., Käse M., Bäumer R., Ringelstein E.B., Assman G. Plasminogen activator inhibitor-1 4G/5G genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers. Thromb Haemost. 80:1998;706-707.
7. Akar N., Akar E., Dalgin G., Sözüöz A., Ömürlü K., Cin Ş Frequency of factor V (1691 G-A) mutation in Turkish population. Thromb Haemost. 78:1997;1527-1528.
8. Margaglione M., Grandone E., Capucci G., Giuliani N., Vechione G., De Addedda M., Minno G. An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost. 77:1997;605-606.
9. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88:1996;3698-3703.
10. Gandrille S., Alhenc-Gelas M., Aiach M. A rapid method for the factor V Arg 506-Gln mutation. Blood Coagul Fibrinol. 6:1995;245-248.
11. Akar N., Misirlioglu M., Akar E., Avcu F., Yalçin A., Sözüöz A. Prothrombin 20210G-A mutation in the Turkish population. Am J Haematol. 58:1998;249.
12. Leiden and thrombophilia. Arterioscler Thromb Vasc Biol. 17:1997;620-627.